Browsing: Genitourinary

Headline: Modern post-cystectomy radiation isn’t as toxic as radiation of yore.The Study: The phase 3 BART trial comparing adjuvant radiation…

Top Line: Should 177Lu-PSMA be used in the first-line setting for metastatic prostate cancer?The Study: 177Lu-PSMA is currently used to…

RTOG 0712 was a phase 2 trial that evaluated 2 different bladder preservation regimens in 70 patients with muscle invasive…

Top Line: FASTRACK IIhttps://quadshotnews.com/still-on-the-fastrack/ established the safety and impressive efficacy of definitive SBRT for inoperable renal cell carcinoma.The Study: Here…

Top Line: Adjuvant post-cystectomy radiation is looking to make a comeback touting modern radiation techniques.The Study: You know who is…

While associations between use of wildly popular GLP1-agonists and increased incidence of medullary thyroid cancer are previously reported, big data…

This paper outlines the European Society of Radiation Oncology (ESTRO) and European Association of Urology (EAU) consensus recommendations for the…

A meta-analysis of clinical trials evaluating the efficacy of immune checkpoint inhibitors (ICI) for metastasis urothelial carcinoma (there’s been 14,…

Top Line: Blockbuster results with non-surgical management of localized renal cell carcinoma (RCC) via SBRT were presented in abstract form…